Status:
COMPLETED
Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate the effectiveness of Rosuvastatin versus Ezetimibe/Simvastatin in dyslipidemic patients treated for at least 8 weeks.
Eligibility Criteria
Inclusion
- Dislipidemic population treated with rosuvastatin or ezetimibe/simvastatin for at least for 8 weeks
- Who have completed at least 80% of the treatment
- To have determinations at least of CT, TG C-LDL and CHDL before starting treatment and after 8 weeks of taking the medicine
Exclusion
- Initiating different therapy lipid lowering to Rosuvastatin or Ezetimibe/Simvastatin
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT01164397
Start Date
April 1 2009
End Date
December 1 2010
Last Update
January 18 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Guadalajara, Jalisco, Mexico
2
Research Site
Mexico City, Mexico City, Mexico
3
Research Site
Cuernavaca, Morelos, Mexico
4
Research Site
Monterrey, Nuevo León, Mexico